雷贝拉唑、克拉霉素联合阿莫西林治疗胃溃疡的疗效及不良反应分析
贺东,李苗苗
(1.陕西省榆林市绥德县满堂川乡卫生院内科,陕西 榆林,718002;2.陕西省榆林市绥德县医院心血管内科, 陕西 榆林,718000)
浏览次数:85次 下载次数:307次
摘要:
目的 探讨分析雷贝拉唑、克拉霉素联合阿莫西林治疗胃溃疡的疗效及不良反应发生情况。方法 将2012年1月至2013年1月我院收治的180例胃溃疡患者随机分成对照组和观察组。对照组90例采用克拉霉素、阿莫西林、奥美拉唑联合用药治疗;观察组90例采用克拉霉素、阿莫西林、雷贝拉唑联合治疗。比较两组患者的临床疗效。结果 治疗后,两组CRP、IL-6、 IL-2水平均改善(P<0.05),观察组患者的CRP、IL-6水平明显低于对照组,IL-2水平明显高于对照组(P<0.05)。对照组治疗总有效率为71.11%,观察组治疗总有效率为91.11%,组间差异显著(P<0.05)。对照组患者不良反应总发生率为11.11%,高于观察组的2.22%(P<0.05)。结论 雷贝拉唑、克拉霉素联合阿莫西林治疗胃溃疡疗效确切,安全性高,值得临床推广。
关键词:三联用药;胃溃疡;克拉霉素;雷贝拉唑;阿莫西林
中图分类号:R573.1文献标志码:A文章编号:2096-1413(2017)22-0079-02
Efficacy and adverse effects of rabeprazole and clarithromycin combined with amoxicillin in the treatment of gastric ulcer
HE Dong 1, LI Miao-miao 2
(1. Department of Internal Medicine, Mantangchuan Township Health Center of Suide County, Yulin 718002;
2. Department of Cardiology, Suide County Hospital, Yulin 718000, China)
ABSTRACT: Objective To investigate the efficacy and adverse reactions of rabeprazole and clarithromycin combined with amoxicillin in the treatment of gastric ulcer. Methods One hundred and eighty patients with gastric ulcer were randomly divided into control group and observation group. The control group (n =90) was given clarithromycin, amoxicillin and omeprazole, while the observation group (n=90) accepted clarithromycin, amoxicillin and rabeprazole combination therapy. The clinical efficacy of the two groups was compared. Results After treatment, the levels of CRP, IL -6 and IL -2 significantly improved in both groups (P<0.05); the levels of CRP and IL-6 in the observation group were significantly lower than those in the control group, IL -2 level was significantly higher than that in the control group (P<0.05); the total effective rate of the control group was 71.11% , which was lower than 91.11% in the observation group (P<0.05). The adverse reaction rate in the control group was 11.11%, which was significantly higher than 2.22% in the observation group (P<0.05). Conclusion Rabeprazole, clarithromycin combined with amoxicillin in the treatment of gastric ulcer is effective, safe, and it can be widely used in clinical practice.
KEYWORDS: triple therapy; gastric ulcer; clarithromycin; rabeprazole; amoxicillin
参考文献:
[1] 庄秀梅.泮托拉唑治疗2 型糖尿病合并胃溃疡的临床疗效探讨[J].糖尿病新世界,2016,19(7):88-89.
[2] 程艳艳.奥美拉唑联合抗生素治疗胃溃疡的疗效及不良反应观察 [J].中国继续医学教育,2016,8(16):160-161.
[3] 刘新宇,陈普群,白凤芝.药物四联治疗Hp 相关性胃溃疡疗效及不良反应分析[J].中外医疗,2016,35(19):150-151.
[4] 于志富.痛泻要方加减联合奥美拉唑肠溶胶囊治疗胃溃疡(肝气犯胃证)的临床观察[D].贵阳:贵阳中医学院,2014.
[5] 孙祥瑞.泮托拉唑的有效性和安全性评价及某院用药合理性分析[D].合肥:安徽中医药大学,2015.
[6] 王彬彬.泮托拉唑治疗胃溃疡的疗效观察[J].中国医药指南,2015,3(4):184-185.
[7] 常艳萍.奥美拉唑治疗72 例胃溃疡的疗效评价[J].临床医药文献电子杂志,2015,2(8):1527-1528.
[8] 董占玲.不同质子泵抑制剂治疗胃溃疡的临床疗效对比研究[J].中国处方药,2015,13(6):74-75.